Tests vitamin D3 effect on brain waves in men with Parkinson's disease
Tests vitamin D3 capsules on brain waves in men with Parkinson's.
Plain-language title generated from the registry record
Registry title: Effect of Vitamin D3 on Brain Waves in Male Parkinson's Patients With Low Vitamin D: A qEEG Study
Key facts
- Where
- Dhaka, BangladeshSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 51 and 70 years old?
Source: NCT07096336, who can take part
Where in Bangladesh
- Bangladesh Medical UniversityDhaka, BangladeshTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bangladesh Medical University
- Trial code
- NCT07096336
- Record updated
- 31 July 2025
- Original description
This is an experimental study (Interventional self-controlled trial, pretest-posttest design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male Parkinson's disease patients with hypovitaminosis D.Read full original descriptionShow less
Effect of Vitamin D3 Supplementation on Brain Waves in Male Parkinson's Disease Patients With Hypovitaminosis D : A Quantitative Electroencephalogram Analysis
This is an experimental study (Interventional self-controlled trial, pretest-posttest design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male Parkinson's disease patients with hypovitaminosis D.
The main question it aims to answer is:
Vitamin D3 supplementation has effect on brain waves in male Parkinson's disease patients with hypovitaminosis D.
Researcher will compare the effect of vitamin D3 supplementation on brain waves in male Parkinson's disease patients with hypovitaminosis D with their pre intervention ( baseline ) condition on brain waves to assess whether there will be any improvement of brain electrical activity by quantitative electroencephalogram (QEEG).
Participants will :
Take vitamin D3 orally for 8 weeks (50,000 IU/week) Visit the medical university after 8 weeks for evaluation of serum 25(OH)D level and QEEG Must bring the empty strips of vitamin D supplement with them during their visit.
Inclusion: Male Patients with PD up to stage 3 according to Hoehn and Yahr (H-Y) scale; Age: 51years to70 years; BMI: 18.5-24.9 kg/m2; Hypovitaminosis D (Serum 25(OH)D level <30 ng/ml); Patients on Levodopa therapy.
Exclusion: Current use of medication/substances known to affect neuronal excitability or EEG patterns, such as - sedatives, antidepressant, antipsychotics, alcohol; Patients who are currently suffering from following diseases; Neurological disorders (Migraine, epilepsy); Cardiovascular disorders (Myocardial infarction, hypertension, cardiac arrhythmia, heart failure); Respiratory disorders (Bronchial asthma, COPD); Psychiatric illness (e.g., schizophrenia, major depression, bipolar disorder, severe dementia); With biochemical evidence of-; Hypercalcemia; Renal insufficiency; Liver diseases; Endocrine disorders (uncontrolled diabetes mellitus, Hypothyroidism, Hyperthyroidism); Already taking vitamin D3 supplements; Active smoker.